SCHEMBL31228219

SCHEMBL31228219

Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@](F)(CO)[C@@H](O)[C@H]1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 12/20 0.61
▸ ADORA2A P29274 6/20 0.61
▸ ADORA1 P30542 5/20 0.61
▸ PDE4D Q08499 2/20 0.61
▸ PDE3A Q14432 2/20 0.61
▸ PDE2A O00408 2/20 0.61
▸ ADRA1A P35348 1/20 0.61
▸ HSP90AA1 P07900 1/20 0.55
▸ HSP90B1 P14625 1/20 0.55
▸ CA1 P00915 1/20 0.52
▸ CA2 P00918 1/20 0.52
▸ CA4 P22748 1/20 0.52
▸ CA9 Q16790 1/20 0.52
▸ ADORA2B P29275 2/20 0.51
▸ PNP P00491 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31228269 0.88 NT5E (0.62) ADORA3ADORA2AADORA1PDE4DPDE3A
SCHEMBL28989081 0.84 ADORA2A (0.48) ADORA3ADORA2AADORA1ADORA2BLMNA
SCHEMBL13844404 0.83 PRMT5 (0.61) ADORA3ADORA2AADORA1ADORA2BSMN1; SMN2
SCHEMBL31652936 0.83 ADORA3 (0.58) ADORA3ADORA2AADORA1PDE4DPDE3A
SCHEMBL32670344 0.83 ADORA3 (0.58) ADORA3ADORA2AADORA1PDE4DPDE3A
SCHEMBL31652975 0.83 ADORA3 (0.58) ADORA3ADORA2AADORA1PDE4DPDE3A
SCHEMBL31725323 0.80 AHCY (0.49) ADORA3ADORA2AADORA1PDE4DPDE3A
SCHEMBL31725350 0.79 NT5E (0.60) ADORA3ADORA2AADORA1PDE4DPDE3A
SCHEMBL745409 0.78 ADORA3 (0.64) ADORA3ADORA2AADORA1PDE4DPDE3A
SCHEMBL745410 0.78 ADORA3 (0.64) ADORA3ADORA2AADORA1PDE4DPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP claimed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO claimed
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP disclosed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO disclosed
Send feedback